1,704
Views
23
CrossRef citations to date
0
Altmetric
Review

The emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease

, &
Pages 147-153 | Received 10 Dec 2019, Accepted 22 Jan 2020, Published online: 31 Jan 2020
 

ABSTRACT

Introduction: Dipeptidyl-peptidase-4 (DPP-4) is a surface bound ectopeptidase that is commonly known as CD26 or adenosine deaminase binding protein. DPP-4 is membrane anchored but it can be cleaved by numerous proteases including matrix-metalloproteinases (MMPs). DPP-4 is expressed by endothelial and epithelial cells, the kidney, intestine and cells of the immune system; it has a broad spectrum of biological functions in immune regulation, cancer biology and glucose metabolism.

Areas covered: This article sheds light on the functions of DPP-4, the molecular mechanisms that govern its expression, it’s role in the pathogenesis of common respiratory illnesses and potential as a therapeutic target.

Expert opinion: DPP-4 has a deleterious role in respiratory disease. Its biological functions, key molecular pathways, interactions and associations are slowly being elucidated. Progressing our knowledge of the role of this multi-faceted molecule may yield vital and novel therapies for respiratory diseases such as lung cancer, asthma, and chronic obstructive pulmonary disease (COPD).

Article highlights

  • DPP-4 can regulate the immune response, particularly with respect to T-cell activation and homeostasis by modulating chemotaxis.

  • DPP-4 inhibition alleviates arterial remodeling in experimental pulmonary hypertension via inhibition of pulmonary arterial smooth muscle cell proliferation and migration.

  • DPP-4 is also implicated in the pathophysiology of asthma and strongly associates with COPD due to its role in immune function.

  • DPP-4 inhibition showed improved overall survival in lung cancer patients by acting on tumor immunoregulation.

  • Biopharmacological inhibition of DPP-4, with the use of antibodies, DNA vaccines and small interfering RNA, is emerging as a promising novel therapeutic target in respiratory diseases and cancer.

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose

Additional information

Funding

This paper was not funded.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,049.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.